TuHURA Biosciences, Inc.
HURA
$2.46
-$0.16-6.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | |||
|---|---|---|---|---|---|
| Net Income | -37.63% | -123.55% | -- | ||
| Total Depreciation and Amortization | -58.89% | -51.11% | -- | ||
| Total Amortization of Deferred Charges | -- | 3,260.78% | -- | ||
| Total Other Non-Cash Items | 341.77% | 893.83% | -- | ||
| Change in Net Operating Assets | -23.12% | 527.20% | -- | ||
| Cash from Operations | -23.58% | 14.22% | -- | ||
| Capital Expenditure | -- | 46.10% | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | -- | -1,974.31% | -- | ||
| Total Debt Issued | -- | -100.00% | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -83.62% | -- | -- | ||
| Cash from Financing | -111.83% | -230.94% | -- | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -908.20% | -1,701.82% | -- | ||